Professor of Health Economics & Director, HERC
- Professor of Health Economics, University of Oxford
- Academic, Melbourne School of Population and Global Health
- Honorary, Melbourne Institute of Applied Economic and Social Research
Professor Philip Clarke re-joined HERC in August 2018 after previous appointments at the Universities of Sydney and Melbourne in Australia. He is a Fellow of the Academy of the Social Sciences in Australia (ASSA).
His research interests include developing methods to value the benefits of improving access to health care, health inequalities and the use of simulation models in health economic evaluation. Philip has been involved in the development of the UKPDS Outcomes Model, a health economic simulation model for type 2 diabetes.
Reply to Spreco et al.: Perceived corruption and preferences for COVID-19 vaccine allocations.
Duch R. et al, (2022), Proc Natl Acad Sci U S A, 119
Patient and clinician characteristics and preferences for increasing participation in placebo surgery trials: a scoping review of attributes to inform a discrete choice experiment.
Hinwood M. et al, (2022), Trials, 23
Eliciting risk preferences that predict risky health behavior: A comparison of two approaches.
Yang M. et al, (2022), Health Econ
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.
Chan JCN. et al, (2021), Lancet, 396, 2019 - 2082
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge.
Tew M. et al, (2021), Med Decis Making